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ABSTRACT
Introduction: Genotoxic biomarkers have been
studied largely in adult population, but few studies so
far have investigated them in children exposed to air
pollution. Children are a high-risk group as regards the
health effects of air pollution and some studies
suggest that early exposure during childhood can play
an important role in the development of chronic
diseases in adulthood. The objective of the project is to
evaluate the associations between the concentration of
urban air pollutants and biomarkers of early biological
effect in children, and to propose a model for
estimating the global risk of early biological effects due
to air pollutants and other factors in children.
Methods and analysis: Two biomarkers of early
biological effects, DNA damage by the comet assay and
the micronuclei (MN) test, will be investigated in oral
mucosa cells of 6–8-year-old children. Concurrently,
some toxic airborne pollutants (polycyclic aromatic
hydrocarbon (PAH) and nitro-PAH) and in vitro air
mutagenicity and toxicity in ultra-fine air particulates
(PM0.5) will be evaluated. Furthermore, demographic
and socioeconomic variables, other sources of exposures
to air pollutants and lifestyle variables will be assessed
by a structured questionnaire. The associations between
sociodemographic, environmental and other exposure
variables and biomarkers of early biological effect using
univariate and multivariate models will be analysed. A
tentative model for calculating the global absolute risk of
having early biological effects caused by air pollution and
other variables will be proposed.
Ethics and dissemination: The project has been
approved by the Ethics Committees of the local Health
Authorities. The results will be communicated to local
Public Health Agencies, for supporting educational
programmes and health policy strategies. LIFE+2012
Environment Policy and Governance. LIFE12 ENV/IT/
000614.
INTRODUCTION
Air pollution is a global problem, especially
in urban areas.1 In particular, particulate
matter (PM) has been studied intensely as
regards its effects on human health. PM con-
sists of breathable particles to which several
compounds, such as heavy metals, polycyclic
aromatic hydrocarbons (PAHs) and some
volatile compounds, may adhere.
Epidemiological studies have found a consist-
ent association between exposure to airborne
PM and incidence and mortality for cardio-
vascular disease and lung cancer and natural-
cause mortality.2–9 Recently, also diabetes
and other chronic diseases have been asso-
ciated with PM exposure, possibly through
oxidative stress and inflammation.10
The finest fractions of PM (PM with aero-
dynamic diameter <2.5 µm and less) play a
Strengths and limitations of this study
This project has some strengths compared with
previous studies on the effects of air pollution on
human health:
▪ Direct measures of air pollution exposure using
data on daily concentration of fine particulate
matter, including PM10 and PM2.5, nitrogen
dioxide, ozone, carbon monoxide, sulfur dioxide
and benzene and evaluation of toxicity and muta-
genicity of urban air using in vitro mutagenicity
and toxicity tests on PM0.5 extracts;
▪ Direct measures of biological effect in buccal
mucosa cells of 1000 children enrolled in
various areas and in two different seasons, that
is, MN frequency and DNA damage, which have
been shown to be predictive of cancer develop-
ment later in life.
The main limitations of this study are:
▪ The biomarkers examined are not specific, as
DNA damage can be caused by numerous envir-
onmental and individual (genetic and metabolic)
factors;
▪ Weather conditions not suitable for air sampling
(rain, snow, strong wind) may be a limit but
there is nothing that can be done about it.
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major role in causing chronic diseases because they are
retained in the alveolar regions of the lung and diffuse
into the blood stream, inducing inflammation, oxidative
stress and blood coagulation.7 11–13 Extracts of urban air
particles can induce cancer in animals,14 15 and are
mutagenic in bacteria, plant and mammalian cells in in
vitro tests.16–22
Urban air is a complex and variable mixture of many
different chemical species.1 23 The effects of exposure to
such a mixture are not merely the sum of the effects of
each compound, because they can interact with synergis-
tic effects; moreover, one or more chemicals can cause
different effects and have multiple cellular targets.24 It
has been reported that even moderate or low levels of
air pollution can contribute to carcinogenesis.7 23
Indeed, due to the very large number of people
exposed to air pollutants, even a small increase in the
risk of disease is a relevant public health issue.
Among the several adverse health effects associated
with exposure to air pollutants, genetic damage has
received a particular interest, especially because a high
frequency of markers of chromosomal damage, such as
chromosomal aberrations and micronuclei (MN) in per-
ipheral blood lymphocytes, has been found to predict
cancer occurrence in cohort studies.25–27
Genetic biomarkers have been studied largely in adult
population, but only few studies so far have investigated
genetic damage in children exposed to air pollution.27–31
In recent years MN frequency in buccal mucosa (BM)
cells of children or young adults has been studied
showing cytogenetic damage in participants who lived in
areas with high concentration of PM or oxidant pollu-
tants.32–37
Recently, Ceretti et al37 found a higher MN frequency
than that observed in a pooled general population of
the same age27 in exfoliated buccal cells of preschool
children living in a highly polluted town in the Po Valley
in Italy.
On the other hand, studies of genetic damage in chil-
dren are of the utmost interest because children are a
high-risk group as regards the short-term and long-term
health effects of air pollution.38–43 Indeed, some studies
suggest that early exposure during childhood can play
an important role in the development of chronic dis-
eases in adulthood: the earlier the exposure, the greater
the risk of chronic disease, including cancer.44
The MN test is a mutagenicity test widely used as a
marker of early biological effects due to its ability to
detect both clastogens and aneuploidy-inducing chemi-
cals.45 MN appear in the cytoplasm of interphasic cells
as small additional nuclei, smaller than main nuclei.
They are formed of acentric chromosomal fragments or
whole chromosomes that are not included in the main
daughter nuclei during nuclear division. MN induction
therefore reflects clastogenic and/or aneugenic events.
The primary DNA damage may be studied also using
the comet assay (single cell gel electrophoresis test),
which is one of the genotoxicity tests that rapidly detects
DNA damage in eukaryotic cells. In alkaline conditions,
it detects single-stranded and double-stranded breaks,
alkali labile sites, incomplete repair sites and possibly
also DNA–DNA and DNA–protein cross-links. The
comet test shows very early, reversible DNA damage that
represents a marker of early biological effect.46–49
The MN frequency and the primary DNA damage, as
markers of early biological effect, may be studied in dif-
ferent types of cells, such as lymphocytes and exfoliated
cells from nasal and BM, and from urine.30 49 Buccal
cells are certainly easier to collect than blood and do
not require highly trained personnel. Moreover, collec-
tion of BM cells is considered more acceptable to chil-
dren and therefore more useful in studies on the
paediatric population.
The main objective of the project is to analyse the
associations between some air pollution parameters
(PM10, PM2.5, PM0.5, NOx, PAHs and nitro-PAHs) and
two biomarkers of early effect, and to propose a model
for estimating the global risk of early biological effects
due to air pollutants and other factors including demo-
graphic and socioeconomic factors, indoor exposures,
diet, physical activity, body mass index (BMI) in school
children. These data will provide information valuable
for guiding policy-making and planning individual and
community interventions to protect children from pos-
sible health effects of air pollutants. This objective will
be achieved studying two biomarkers of DNA damage,
the comet assay and the frequency of MN, in oral
mucosa cells of 6–8-year-old children, and the following
exposure variables, as possible risk factors: airborne pol-
lutants, in vitro air mutagenicity and toxicity, exposures
to other indoor/outdoor pollutants, demographic and
socioeconomic variables, and lifestyle variables. The
project will also be useful for increasing the sensitivity of
people to air pollution concerns and promote the local
authorities’ involvement in efforts to reduce urban air
pollutants.
METHODS AND ANALYSIS
Study design
The MAPEC project runs 3 years (2014–2016). The core
of the study is a prospective epidemiological cohort
study to evaluate and disseminate a method for monitor-
ing biological effects of air pollution on children, with
regard to biological parameters that can predict the
occurrence of chronic diseases in adult age. Markers of
early biological effect, such as primary DNA damage
evaluated with the comet assay and presence of MN, will
be investigated in BM cells taken from 6–8-year-old chil-
dren living in five Italian towns (Brescia, Turin, Pisa,
Perugia and Lecce), with different levels of airborne par-
ticulates (PM10 annual average from 44 µg/m3 mea-
sured in Torino to 20 µg/m3 measured in Lecce).50
Child exposure to urban air pollution will be evaluated
by collecting ultra-fine PM (PM0.5) samples in the
school areas, on the same day of biological sampling.
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The particulate samples will be analysed for PAH and
nitro-PAH concentration and for in vitro toxicity and
mutagenicity/genotoxicity. In support of these analyses,
data on airborne pollution routinely analysed by local
authorities responsible for its control will be collected,
referring to the air monitoring units closest to the
schools participating in the MAPEC project, in the five
cities. Biological and air samples will be repeated in
winter and spring, seasons characterised by different
type and concentration of air pollutants. Other indoor
and outdoor exposures will be investigated using an ad
hoc questionnaire administrated to children’s parents
that includes questions on possible confounders and
interaction factors, such as demographic and socio-
economic variables, children’s lifestyle, with a focus on
diet and physical activity. In conclusion, the whole data
set will be analysed to investigate the association
between air pollution exposure measures (chemical pol-
lutants and PM toxicity and mutagenicity/genotoxicity)
and the early effect biomarkers with the aim of develop-
ing a model for calculating the global absolute risk of
early biological effects of air pollution and other pos-
sible exposure data obtained by the questionnaire.
Sample size
A total of 1000 children (200 children per town) aged
6–8 years will be recruited from first grade schools. Two
to four schools in each town will be chosen randomly
from the list of schools located in areas without adjacent
air pollution emission sources. The teachers, school per-
sonnel and children’s parents will be involved in meet-
ings where members of the research team will explain
the project and promote participation. Participation in
the study will be voluntary and no incentive will be
offered for this.
The sample size of the study has been determined in
order to detect statistically significant differences in the
early effect biomarkers, that is, primary DNA damage
and MN, between children living in towns with high and
low air pollution levels. Based on published studies com-
paring groups at different levels of exposure to airborne
mutagens, we expect to observe DNA damage in the
comet test, evaluated as an average of 10% of DNA in
comet tail (tail intensity) among participants with
higher air pollution exposure levels compared with 7%
in those at a lower exposure levels with an SD of 10%.
By enrolling a total of 1000 children, about 40% of
whom are supposed to live in highly polluted towns
(Brescia and Turin which are located in the Po Valley),
and assuming a log-normal distribution of the biomar-
kers of early effect, we expect to observe a statistically sig-
nificant difference between the two groups, with an α
error of 0.05 and a power higher than 95%, using a
Student t test for independent groups at two tails.
Estimating a loss of approximately 20%, because of
incomplete or incorrectly compiled questionnaires and/
or an insufficient number of cells collected through bio-
logical sampling, an oversampling of participants will be
necessary, therefore a total of 1300 children will be
recruited.
Inclusion/exclusion criteria
Only children living in the participating towns will be
recruited. Children with severe diseases and those who
have been exposed to antineoplastic agents, have under-
gone radiation therapy or X-rays in the previous
12 months or have a dental prosthetic will be excluded.
Questionnaires
An ad hoc questionnaire will be designed including
items on demographic and socioeconomic variables,
exposures to indoor and outdoor air pollution sources,
characteristics of the area of residence, parents’ smoking
at home, BMI, children’s respiratory symptoms and dis-
eases, diet, physical activity and other aspects of chil-
dren’s lifestyle. The questionnaire will be based on
others used in some international studies on children’s
respiratory diseases performed in recent decades.51
After a pretesting phase, the reliability of the question-
naire will be assessed on about 100 participants using
the test–retest method.
The questionnaires will be distributed and collected
with the help of the school personnel at two separate
times, in winter and late spring (before school closing
for summer holidays), from the 1000 children enrolled
(2 questionnaires per each child), in the weeks in which
environmental and biological samplings will be
performed.
For children not providing a filled in questionnaire,
further attempts will be made on the next days. As bio-
logical samplings will go on for some days, the samples
for some of the children absent from school on the
established day for taking oral mucosa cells will be
retrieved during the whole period of biological
sampling.
In order to evaluate the intraindividual variability of
biomarkers of early effect, a third environmental and
biological sampling will be carried out in the following
winter, restricted to 200 children recruited in Brescia.
Collection of environmental samples
Ultra-fine PM (PM0.5) will be collected near the schools
involved in the research. A high-volume air sampler will
be located near the schools for 72 h during the days of
biological sampling, both in winter and spring.
Furthermore, air and biological samplings will be
repeated in the following winter in Brescia. PM0.5 sam-
pling will be carried out using fibreglass filters. All the
filters will be weighed for gravimetric determination of
PM0.5 and then will undergo organic extraction using
sonication to prepare the samples for in vitro mutageni-
city/genotoxicity and toxicity tests and chemical analysis.
Chemical analysis
The chemical analysis of PM0.5 extracts collected in
each town for the determination of PAHs and
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nitro-PAHs will be performed at a single laboratory
using high pressure liquid chromatography.
Mutagenicity of ultra-fine PM: Ames test
The mutagenicity of PM0.5 organic extracts collected in
all towns will be evaluated using Ames test on bacteria.
This test is a short-term mutagenicity test which detects
point mutations (base substitution and frameshift muta-
tions) in Salmonella typhimurium strains.52 53 The PM0.5
organic extracts, dissolved in a compatible solvent
(dimethylsulphoxide; DMSO), will be tested in duplicate
at increasing doses with S. typhimurium TA100 and TA98
strains, which are generally utilised for environmental
studies,18 and NR98 and YG1024 strains, which are par-
ticularly able to detect nitrocompound.20 54 The Ames
test will be performed with and without metabolic activa-
tion (±S9), adding microsomal enzymes of rat liver to
detect direct and indirect mutagens. Plates will be incu-
bated at 37°C in the dark for 72 h, after which revertant
colonies will be counted and a dose–response curve will
be constructed. The net amount of revertants per cubic
metre of air equivalent will be evaluated using a linear
regression model. The Ames test will be performed at
the same laboratory on all samples.
Genotoxicity of ultra-fine PM
The genotoxicity of PM0.5 organic extracts collected in
all towns will be evaluated using comet test and MN test
on human pulmonary A549 cell line.
Comet assay
The comet assay is a sensitive genotoxicity test which
detects primary DNA damage in individual eukaryotic
cells. This assay will be carried out on human cells of
the respiratory system (A549), which represent the first
type of tissue in contact with the airborne pollutants.
The organic extracts of PM0.5 will be transferred to a
compatible solvent (DMSO) and tested (24 h at 37°C
with 5% CO2) in duplicate at increasing doses using A549
cells. The comet assay will be performed in alkaline con-
ditions (pH>13) with the protocol to detect oxidative
damage using endonuclease (formamidopyrimidine
DNA glycosylase) incubation.55 56 The comet will be
examined using an image analysis system (Comet Assay
IV). Results will be expressed as genotoxic parameter per
cubic metre of air equivalent. All samples will be analysed
at a single laboratory.
Cytokinesis-block MN test
The genotoxicity of PM0.5 organic extracts collected in
the five towns will be evaluated using the cytokinesis-
block MN (CBMN) test. The CBMN test will be per-
formed in accordance with the original method by
Fenech57 on human A549 cells treated in vitro with air
extracts. At the end of the in vitro treatment, the
medium will be replaced by fresh medium containing
cytochalasin B to inhibit cell division after mitosis. The
cells will be harvested by trypsinisation and fixed with
Carnoy’s reagent, and the cell suspensions will be
poured onto precleaned frosted microscope slides. After
drying, the slides will be stained, air dried and mounted
with Eukitt. Cells will be examined for MN at 400× mag-
nification according to established criteria.45 MN will be
scored in 1000 binucleated cells for each concentration
of each repeated experiment. Two independent evalua-
tions will be performed for each sample. All samples will
be analysed at a single laboratory.
Toxicity of ultra-fine PM
Specific potential lung toxicity of organic extracts of
PM0.5 will be assessed in vitro on a total of 10 unique
samples, obtained by mixing the organic extracts from
all the samples individually collected from each town
and each season. Cell viability will be assessed by the use
of two traditional colorimetric assays: the MTT (3,(4,5-
dimethylthiazol-2)2,5 difeniltetrazolium bromide) dye-
based assay58 and the neutral red dye-based assay.59
Organ-specific toxicity/non-genotoxic, tumour-
promoting potential of the samples will be evaluated by
testing their influence on the gap junctional function
(GJIC) of suitable epithelial cells (eg, primary culture of
oral mucosae cells or highly junctionally coupled cell
line). According to the cell type selected, the scrape-
loading technique60 or the microinjection/dye-transfer
assay61 will be used. GJIC was chosen as a biological par-
ameter in our study, since its evaluation still represents
one of the most promising and sensitive end points for
the mechanistic evaluation of organ-specific toxicity
and/or tumour-promoting potential of agents.62 63 This
particular form of cell-cell communication is, in fact, a
unique cell/tissue-specific cellular function, with an
unquestioned role in integrated regulation of growth,
differentiation processes and functions of multicellular
organisms and in tissue homoeostatic control.64
Toxicity tests on all PM0.5 extracts will be performed
at a single laboratory.
Collection of urban air chemical data
Data regarding the main air pollutants for which
routine measurements are performed by local author-
ities (Regional Agency for Environmental Protection,
ARPA Italian acronym for Agenzia Regionale per la
Protezione dell’Ambiente), such as CO, NO2, SO2,
benzene, O3, PM10 and PM2.5, will be retrieved for
each town.
Sampling of oral mucosa cells
Biological samples will be collected from all the children
in winter and in late spring (1000×2=2000 samples).
Intraindividual variability of early effect biomarkers will
be evaluated by collecting further biological samples
from 200 children enrolled in Brescia during the follow-
ing winter. In order to collect BM cells, the children will
rinse their mouths twice with mineral water and the
mouthwashes will be collected in tubes containing
25 mL of saline solution (NaCl 0.9%) to obtain
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leucocytes for the comet assay.65 Disposable cytobrush
cell collectors will then be used to collect exfoliated
buccal cells for the MN test by scraping the inside of
both cheeks gently and dipping the material into tubes
containing 15 mL of phosphate buffered saline solution.
Early biological effects in children
Comet assay
An in vivo assessment of primary DNA damage will be
performed on leucocytes of the children’s BM with the
comet assay.65 In order to evaluate primary DNA damage
caused by exposure to air pollutants, the comet assay in
alkaline conditions (pH>13) will be performed to show
single-strand and double-strand breaks and alkali labile
sites.55 The comet assay will also be performed to detect
oxidative damage using endonuclease (formamidopyri-
midine DNA glycosylase) incubation.56 All the slides will
be dried and sent to the same laboratory for microscopic
analysis. After rehydration and staining with a DNA inter-
calating fluorochrome (ie, ethidium bromide or SYBR
green), the analysis will be performed using a fluores-
cence microscope at 400× magnification, equipped with a
digital camera. An average of 100 randomly selected
nuclei per participant will be acquired. The images,
acquired in TIFF (tagged image file format) format, will
be evaluated and the following damage parameters mea-
sured for each nucleoid: comet tail length (TL), percent-
age of detectable DNA in the tail (%TDNA), tail moment
(TM) and Olive TM (OTM).
MN test
The MN test will be performed on BM cells from the
children. For this purpose, the BM scraped cells suspen-
sion will be used to prepare the slides according to
Thomas et al.66 The slides will be stained in light green
using the Feulgen method. The dried slides will be
mounted with Eukitt and sent to a single laboratory for
microscopic analysis. For microscope analysis, the slides
will be examined under microscope at 400× magnifica-
tion. According to proposed scoring criteria,66 67 before
MN frequency calculation, BM cells will be gathered
into categories (ie, ‘normal’ or ‘abnormal’) on the basis
of cytological and nuclear features indicating DNA
damage, cytokinetic failure or cell death. MN frequency
will be then assessed by two well-trained operators in at
least 2000 normal cells per participant.
Risk analysis based on environmental data
A quantitative estimate of carcinogenic risk will be pro-
duced using some risk analysis models, which are based
on standard air pollution parameters (PM10, NOx and
others) routinely collected by local authorities, and the
parameters investigated in this study (PM0.5 content of
PAHs and nitro-PAHs). For carcinogenic substances, the
risk (R) represents the probability of a rise, with respect
to the usual conditions of life, in the number of cases of
cancer in a person’s lifetime caused by exposure to the
substance. The risk analysis will be conducted in
accordance with the RBCA (Risk-Based Corrective
Action) procedure proposed by the American Society
for Testing and Materials (ASTM) and will lead to an
estimate of the carcinogenic risk (R) of exposure to pol-
luted air. Afterwards, the model performance in predict-
ing early biological effects in children will be evaluated
by comparing the estimates produced by the risk analysis
models based on environmental data (‘expected’) and
the actual level of biological effect detected in the chil-
dren (‘observed’).
Statistical analysis and construction of a global risk model
The associations between levels of air pollutants, PM
mutagenicity/genotoxicity and early effect biomarkers
will be investigated using various types of regression
models. Questionnaire data will also be analysed, includ-
ing both demographic and socioeconomic variables and
indoor and outdoor exposure variables. Univariate and
multivariate analyses will be performed, considering all
the variables of interest and confounding factors.
Intraindividual variability of early effect biomarkers will
be assessed by comparing the results observed in two
samples taken from 200 children in two consecutive
winter seasons. A comparison of the results of early
effect biomarker tests will be performed between winter
and summer seasons, among all towns and between
those at higher (Brescia and Turin together) and lower
(all the others) levels of PM10 in winter, using the
common statistical techniques for the analysis of con-
tinuous variables, according to their distribution. The
role of interaction factors will be assessed using both
stratified analysis and statistical models. The associations
between the standard (PM10, NOx, etc) and investigated
(PM0.5 content of PAHs and nitro-PAHs) parameters of
air pollution and early effect biomarkers will be deter-
mined in order to evaluate the air pollution parameters
as predictors of biological effect on children. Then a
tentative model for calculating the global absolute risk
of having early biological effects for air pollution and
other variables together (demographic and socio-
economic factors, indoor exposures, physical activity,
diet, BMI and others) will be proposed.
ETHICS AND DISSEMINATION
Participation in the study will be voluntary. Informed
consent will be obtained from the children’s parents
and the children themselves, after an adequate and
understandable explanation of the intent of the study, of
the possible results and their meaning. Only children
with parents’ informed consent signed and a complete
questionnaire will undergo biological sampling. All the
data collected will be treated confidentially in accord-
ance with current Italian legislation on the treatment of
sensitive data (privacy law).
An alphanumeric code (6 letter) will be randomly
generated to identify both biological samples and ques-
tionnaires. In addition to the alphanumeric code, the
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questionnaires will include the child’s name in order to
enroll only the children whose parents decide to partici-
pate in the research and return a written signed
consent. Then this section with the child’s name will be
separated from the rest of the questionnaire and will be
kept apart in a closed archive. Only the research staff
will be allowed to see the children’s personal data.
All data will be analysed in an aggregate and anonym-
ous way for the preparation of scientific reports in which
the children will be not identifiable in any way.
Communication and dissemination activities are key
issues for achieving the main objective of the MAPEC
project. For successful dissemination of study results, mul-
tiple target audiences will be identified, each of them
needs to be addressed in a different manner, using differ-
ent media and with different messages. The key message
to be conveyed by MAPEC will be indications for addres-
sing individual interventions and community policies to
protect children from the health effects of air pollutants.
A dissemination plan will be designed taking into account
the specific language of interest and communication
channel of possible stakeholders: health authorities, scien-
tific community, teachers, children, parents, etc.
Scientific meetings and workshops will be periodically
organised to show preliminary and final results, which
will be presented at national and international confer-
ences and then published in scientific journals. Also
community, environmental and health authorities will
be involved. MAPEC participatory integrated assessment
is an object-oriented approach with the strong engage-
ment of local, national and European Union stake-
holders. Furthermore, the results will be communicated
to Public Health Agencies, and to the Mayor of each
town for supporting health policy decisions. Annual
meetings will be organised with representatives of
national public health institutions and we will organise
an international workshop at the end of the project.
Finally, the general public will be involved. Presentation
of the project objectives, information and results will need
to be tailored to a public or non-scientific audience in
order to ensure effective communication. Lay science arti-
cles in local and national newspapers will be produced
with the aim to reach out to and create a bridge between
scientific and public audiences. Press conferences will be
organised with local and national mass media to present
the project before all workshops. Moreover, a MAPEC
newsletter will be developed and distributed to different
stakeholders and a project website will be developed.
Local Public Health Authorities and teachers will be
involved in developing information and educational
packages, containing lesson plans, enrichment activities
and ideas for encouraging students to adopt healthy life-
styles, which can be used by other schools throughout
the country.
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